InvestorsHub Logo
Followers 25
Posts 2616
Boards Moderated 0
Alias Born 03/28/2013

Re: None

Tuesday, 03/19/2019 9:18:29 AM

Tuesday, March 19, 2019 9:18:29 AM

Post# of 32923
KALY’s Upcoming Annual Report Likely To Trigger $0.01 PPS Run To $0.10




New York, NY -- March 19, 2019 -- InvestorsHub NewsWire -- www.nextbigticker.com -- Kali-Extracts, Inc. (USOTC: KALY) acquired a patented cannabis extraction process in the fourth quarter of 2018. Shortly after the acquisition the company shot from sub-penny land to almost $0.04 on volume that put it in the top 20 most actively traded stocks on the OTC Market. The PPS retraced back to $0.01 and has been holding that price with a healthy trading volume. In the meantime, the company has published research reports on cannabis pharmaceutical developments and testing in addition to announcing its first sales of cannabis extracts for wellness products. KALY is providing CBD extracts for over $1 million worth of CBD infused water produced by Puration, Inc. (USOTC: PURA), and KALY has also introduced its own CBD infused gum. When the annual report is published in April, the first sales will be officially on the books and likely catapult the KALY PPS up to the $0.10 range were it justifiably should be. Between now and the filing of the annual report, the KALY PPS stands to return to its previous $0.04 high on anticipated news regarding its cannabis pharmaceutical developments and wellness product sales. Following the acquisition of the patented cannabis extraction process late last year and the corresponding jump in price and trading volume, the OTC Markets flagged the company in response to the jump in activity. The company has responded by updating all its OTC Markets required reports. Management is likely to mitigate the OTC Market’s concerns sooner or later and see the flag removed which will likely be yet another impetus fueling a KALY PPS run. It could be a good time to accumulate KALY now under $0.04 before the positing of the company’s annual report or the removal of the OTC Markets flag.

Management engaged Goldman Small Cap Research to conduct analyst coverage of the company and file an initial analyst report: KALY Research Report